Young adulthood is marked by major changes in education, employment, relationships, independence and identity. It is also a period when many psychiatric conditions emerge or intensify. Suicidal behavior rarely results from a single cause; instead, it can reflect the interaction of psychological distress, social adversity, genetic vulnerability, sleep disruption, substance use and biological stress responses. By examining these factors together across time, the study addresses a central challenge in modern psychiatry: identifying measurable processes that may help explain changes in risk before a crisis occurs.

The term “stress-response biomarkers” refers to biological measurements that provide clues about how the body detects and manages stress. One of the most important systems involved is the hypothalamic-pituitary-adrenal, or HPA, axis. When the brain perceives a threat, the hypothalamus signals the pituitary gland, which activates the adrenal glands to release cortisol and other hormones. This response is essential for survival, but repeated, prolonged or poorly regulated activation can influence sleep, immune activity, mood and brain function. Biomarkers related to this system may therefore offer a biological window into how chronic stress affects cognition and emotional regulation.

The study’s focus on neurocognitive functioning is equally significant. Neurocognition includes mental processes such as attention, working memory, processing speed, learning, decision-making and inhibitory control. These abilities help people evaluate consequences, shift perspective and regulate impulses, particularly during emotionally intense situations. Difficulties in these areas do not determine whether someone will engage in suicidal behavior, and they should never be treated as a standalone prediction tool. However, changes in cognitive control may affect how a person responds to overwhelming distress, interprets available choices or accesses support during a rapidly escalating crisis.

A longitudinal design allows researchers to move beyond a single snapshot. In a cross-sectional study, biomarker levels and cognitive performance are measured at one point, making it difficult to determine whether one changes before or after the other. A longitudinal investigation instead follows participants over time, repeatedly assessing biological and cognitive measures. This approach can reveal whether baseline stress-related biology is associated with later neurocognitive performance, whether cognitive functioning changes alongside biomarkers, or whether both reflect a third influence, such as depression, trauma exposure, medication use or sleep disturbance.

The wording of the study’s title is important because it refers to an “association,” not proof that stress biomarkers cause cognitive changes or suicidal behavior. Biological measurements are complex and can vary with the time of day, recent food intake, physical activity, illness, medication, menstrual-cycle factors and the immediate emotional environment. Cortisol, for example, follows a daily rhythm and may be influenced by both acute stress and long-term regulation of the HPA axis. Careful statistical modeling and repeated measurements are therefore essential when researchers attempt to distinguish a stable biological pattern from a temporary fluctuation.

The research is especially relevant because young adults at risk for suicidal behavior are not a biologically uniform group. Two individuals may report similar levels of suicidal thoughts while having very different histories of trauma, anxiety, depression, sleep problems, substance exposure or social support. Their stress systems may also respond differently to the same challenge. Some people may show heightened reactivity, while others may display a blunted or poorly timed response after prolonged stress. Studying this variation could help scientists understand why identical psychological symptoms can produce very different patterns of attention, decision-making and emotional control.

If stress-related biomarkers are consistently linked with neurocognitive changes, the findings could eventually support more individualized research and clinical monitoring. Such measures might help identify people who need closer assessment, guide studies of interventions that target stress regulation, or clarify why treatments work for some patients and not others. Possible approaches could include psychotherapy, sleep-focused care, physical-activity programs, medication, social-support interventions and techniques designed to improve emotional regulation. Yet biomarkers are not destiny, and no blood, saliva or physiological measurement can determine with certainty whether an individual will attempt suicide. Clinical judgment and direct, compassionate communication remain indispensable.

The study also highlights the promise and limitations of translational psychiatry, a field that seeks to connect biological mechanisms with real-world mental-health care. Translational research is most valuable when it avoids reducing complex human experiences to a single molecule or laboratory result. Stress biology can illuminate part of the pathway linking adversity to brain function, but it cannot capture the full influence of relationships, culture, economic insecurity, access to care or personal meaning. The strongest future research will likely combine biomarkers with repeated psychological assessments, cognitive testing, digital behavior measures and detailed information about participants’ environments.

By following the relationship between stress-response biology and neurocognitive functioning in young adults vulnerable to suicidal behavior, Toukhy, Jia-Richards, Goodfriend and their colleagues contribute to a growing effort to understand suicide risk as dynamic rather than fixed. The broader message is both scientifically ambitious and clinically cautious: the body’s response to stress may be connected to how the brain manages information and emotion, but that connection must be studied over time and interpreted within the person’s life context. As researchers continue to map these pathways, the ultimate goal is not to label individuals by biology, but to detect suffering earlier and expand opportunities for effective, timely support.

Subject of Research: The longitudinal association between stress-response biomarkers and neurocognitive functioning in young adults at risk for suicidal behavior.

Article Title: The longitudinal association of stress-response biomarkers on neurocognitive functioning in young adults at-risk for suicidal behavior.

Article References: Toukhy, N., Jia-Richards, M., Goodfriend, E. et al. “The longitudinal association of stress-response biomarkers on neurocognitive functioning in young adults at-risk for suicidal behavior.” Translational Psychiatry (2026). https://doi.org/10.1038/s41398-026-04365-z

Image Credits: AI Generated

DOI: 10.1038/s41398-026-04365-z

Conducted as a case–control study involving a total of 264 participants, the research categorized subjects into three distinct groups: individuals who had attempted suicide, non-suicidal psychiatric inpatients, and healthy control subjects without psychiatric diagnoses. Each participant completed comprehensive self-report questionnaires designed to measure multiple facets of empathy and psychopathological symptoms. By examining these dimensions concurrently, the researchers aimed to unravel how divergent components of empathy relate to mental health status and suicidal behavior.

The study particularly focused on subscales of empathy, including Fantasy (FS), Personal Distress (PD), and Perspective Taking (PT), each representing different aspects of empathic engagement. Fantasy involves imaginatively identifying with fictional characters; Personal Distress reflects self-oriented feelings of anxiety and discomfort in interpersonal contexts; while Perspective Taking captures the cognitive ability to consider others’ viewpoints. The findings revealed that individuals who had attempted suicide exhibited significantly elevated FS and PD scores compared to healthy controls, indicating an amplified immersive and self-focused empathic response among this group.

Intriguingly, the relationship between empathy and psychopathology emerged as complex and, at times, counterintuitive. Across all participants, greater psychological distress correlated positively with heightened Fantasy and Personal Distress scores, underscoring a link between empathic immersion and emotional vulnerability. However, the cognitive component of Perspective Taking demonstrated a divergent pattern: suicide attempters showed a significant decrease in this capacity as psychopathology intensified, suggesting impaired ability to adopt others’ perspectives in the depth of their psychological struggles.

Non-suicidal psychiatric inpatients displayed a similar yet statistically non-significant trend toward lower Perspective Taking with increasing distress, which may point to shared but less pronounced deficits in cognitive empathy within clinical populations. Conversely, healthy controls paradoxically exhibited improved Perspective Taking alongside increased psychological distress, perhaps reflecting a form of adaptive empathic regulation or heightened social awareness in the absence of psychiatric pathology.

The observed elevation in Personal Distress among psychiatric and healthy groups further nuanced these associations. Both psychiatric controls and healthy individuals showed significant increases in PD corresponding to rising psychopathology, while suicide attempters’ PD scores only increased non-significantly, hinting at differing emotional regulation mechanisms in those at direct risk of suicide. This suggests that self-oriented emotional distress may be less sensitive to psychopathology severity in suicidal individuals, possibly reflecting distinct neurobiological or psychological processing pathways.

Collectively, these findings challenge simplified models of empathy in mental illness and suicide risk by highlighting an intricate balance between emotional and cognitive empathic domains. The data imply that heightened self-oriented empathy, particularly intense personal distress and imaginative immersion, are linked to greater psychological distress and may be relevant markers in suicide risk assessment. Conversely, cognitive empathy seems to deteriorate in suicidal individuals facing escalating psychopathology, potentially impeding social connectedness and problem-solving abilities.

The clinical implications of these results are profound. Mental health practitioners might consider incorporating detailed assessments of empathy subtypes into routine evaluations of at-risk populations. Emotional self-orientation and diminished perspective taking could serve as indicators warranting targeted interventions. Therapies aimed at modulating excessive personal distress while enhancing cognitive empathy skills could hold promise in mitigating suicidal tendencies.

Moreover, the study underscores the importance of distinguishing between suicidal and non-suicidal psychiatric patients, as empathy profiles do not differ markedly between these groups, suggesting that empathy alone does not delineate suicide risk. Instead, the interplay with psychopathology, especially how psychological distress modulates specific empathy facets, appears critical.

This research also raises compelling questions about the neurobiological substrates underpinning empathy alterations in suicidal behavior. Future studies employing neuroimaging and longitudinal designs could elucidate causal pathways and inform more precise therapeutic approaches. Understanding whether empathy deficits precede suicidal crises or arise as consequences could revolutionize prevention strategies.

Importantly, the findings highlight that empathy is not universally diminished in mental health disorders. Rather, heightened emotional reactivity coexists with cognitive empathic impairments, contributing to a complex psychodynamic profile. This nuanced perspective invites a reevaluation of empathy’s role in psychiatric conditions and suicidal behavior, moving beyond binary assumptions toward sophisticated conceptual frameworks.

The study’s robust methodology, including a sizeable sample and rigorous statistical analyses, lends credibility to these novel insights. However, reliance on self-reported empathy measures may pose limitations, as subjective reporting could be influenced by cognitive biases or current mood states. Expanding research tools to include behavioral and physiological empathy assessments would enhance understanding.

In sum, this pivotal case–control study enriches our comprehension of how empathy interfaces with psychopathology and suicidal behavior, revealing that emotional and self-oriented empathy dimensions hold promise in identifying individuals at heightened suicide risk. By charting these subtle empathic shifts, the research paves the way for more personalized, mechanism-based intervention frameworks, ultimately aiming to reduce the tragic toll of suicide worldwide.

Subject of Research: Empathy, psychopathology, and suicidal behavior

Article Title: Empathy, psychopathology and suicidal behavior: a case–control study

Article References:
Toffol, E., Lussignoli, M., Aliverti, E. et al. Empathy, psychopathology and suicidal behavior: a case–control study. BMC Psychiatry 25, 811 (2025). https://doi.org/10.1186/s12888-025-07230-3

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12888-025-07230-3